WRF
EGRX

Waddell & Reed Financial’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Waddell & Reed Financial’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-56,000
Closed -$2.17M – 619
2016
Q2 		$2.17M Buy
56,000
+11,900
+27% +$462K ﹤0.01% 558
2016
Q1 		$1.79M Hold
44,100
– – ﹤0.01% 574
2015
Q4 		$3.91M Buy
+44,100
New +$3.91M 0.01% 518